medicare contractor insofar as it provides services (including claims processing) for providers of services or suppliers, shall maintain an Internet website which— (1) provides answers in an easily accessible format to frequently asked questions, and (2) includes other published materials of the contractor, that relate to providers of services and suppliers under the programs under this subchapter

(ii) Public disclosureThe Secretary shall make available on a website of the Centers for Medicare & Medicaid Services that is accessible to the public— (I) the total amount of funds expended for each conference conducted under the authority of subsection (b)(4); and (II) the amount of funds expended for each such conference that were for transportation and for travel expenses.

for any further Executive orders issued pursuant to the national emergency declared in E.O. 13818: using the identifier formulation “[GLOMAG-E.O. [E.O. number pursuant to which the person's property and interests in property are blocked]]”. The SDN List is accessible through the following page on OFAC's website: www.treas.gov/sdn. Additional information pertaining to the SDN List can be found

paragraph (a) of this section, are published in the Federal Register and incorporated into OFAC's Specially Designated Nationals and Blocked Persons List (SDN List) with the identifier “[DRCONGO].” The SDN List is accessible through the following page on OFAC's website: www.treasury.gov/sdn. Additional information pertaining to the SDN

OFAC's Specially Designated Nationals and Blocked Persons List (SDN List) using the following identifiers: for E.O. 13667: “[CAR]”; for any further Executive orders issued pursuant to the national emergency declared in E.O. 13667: using the identifier formulation “[CAR-E.O.[E.O. number pursuant to which the person's property and interests in property are blocked]].” The SDN List is accessible through the following page on OFAC's website:

ensuring compliance with this Act or chapter 95 or chapter 96 of title 26, but amounts paid or incurred by the regular employer for such legal or accounting services shall be reported in accordance with section 30104(b) of this title by the committee receiving such services; (ix) the payment by a State or local committee of a political

(A) Qualified census tract (i) In generalThe term "qualified census tract" means a census tract that is covered by the definition of "qualified census tract" in section 42(d)(5)(B)(ii) of title 26 and that is reflected in an online tool prepared by the Administrator described under subsection (d

Section 1651 provided for apprentice or other training on the job. Section 1652 provided for institutional on-farm training for Korean conflict veterans.

), and the peer-review process provided under paragraph (7), and after the release of draft findings with respect to systematic reviews of existing research and evidence. (2) Additional forumsThe Institute shall support forums to increase public awareness and obtain and incorporate public input and feedback through media (such as an Internet website) on research priorities, research findings, and other duties, activities, or processes the Institute

secrets and commercial or financial information (hereinafter referred to as Confidential Business Information (“CBI”)). Comments submitted through http://www.regulations.gov cannot be claimed as CBI. Comments received through the website will waive any CBI claims for the information submitted. For information on submitting CBI, see the Confidential Business Information section. DOE processes submissions made through http://www.regulations.gov

employed, held, used, arising from, or available to such "Office of Inspector General" are hereby transferred to the Office established pursuant to this section. (h) Information on website (1) The Director of the Central Intelligence Agency shall establish and maintain on the homepage of the Agency's publicly accessible website information relating to the Office of the Inspector General including methods to contact the

and feedback through media (such as an Internet website) on research priorities, research findings, and other duties, activities, or processes the Institute determines appropriate. (3) Public availabilityThe Institute shall make available to the public and disclose through the official public Internet website of the Institute the following: (A) Information contained in research findings as specified in

1. Industry Standard 2. Water Pressure C. Other Test Procedure Topics III. Submission

on the toxicological profile for clofentezine is discussed in Unit II.A. of the final rule published in the Federal Register of June 14, 2016 (81 FR 38605) (FRL-9942-23). Specific information on the studies received and the nature of the adverse effects caused by clofentezine as well as the no-observed-adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-level (LOAEL) from the toxicity studies can be found at http

DATES: This final rule is effective on August 8, 2019. ADDRESSES: EPA has established a docket for this action under Docket ID number EPA-R02-OAR-2019-0157. All documents in the docket are listed on the www.regulations.gov website. Although listed in the index, some information is not publicly available, e.g., confidential

characterized as decreased forelimb grip strength or hindlimb grip strength in the F1 pups. There was no adverse effect on reproductive performance at any dose. In the developmental neurotoxicity study, no maternal or offspring toxicity was seen at any dose including the limit dose. Dinotefuran is classified as “Not Likely to be Carcinogenic to Humans” based on lack of evidence of carcinogenicity in rats and mice in two adequate rodent carcinogenicity studies

be unlawful, provided the pesticide was applied in a manner that was lawful under FIFRA, and the residues do not exceed a level that was authorized by this time-limited tolerance at the time of that application. EPA will take action to revoke this time-limited tolerance earlier if any experience with, scientific data on, or other relevant information on this pesticide indicate that the residues are not safe. Because this time-limited tolerance is being

were observed up to the limit dose in the 28-day dermal study in rats. Clothianidin is not carcinogenic or mutagenic. A summary of the toxicological effects of clothianidin, the specific information on the studies received, the nature of the adverse effects caused by clothianidin, and the NOAEL and lowest-observed-adverse-effect-level (LOAEL) from the toxicity studies can be found in docket ID number EPA-HQ-OPP-2011-0865 under Draft Human Health Risk

established a docket for this action under Docket Identification No. EPA-R04-OAR-2019-0155. All documents in the docket are listed on the www.regulations.gov website. Although listed in the index, some information is not publicly available, i.e., Confidential Business Information or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the internet and will be publicly available only in hard copy form. Publicly

document. DATES: This rule will be effective on March 30, 2020. ADDRESSES: The EPA has established a docket for this action under Docket ID No. EPA-R09-OAR-2018-0146. All documents in the docket are listed on the https://www.regulations.gov website. Although listed in the index, some

No effects of toxicological significance were observed in the mouse. Penoxsulam showed no evidence of neurotoxicity or immunotoxicity in the rodent, and no effects were seen in rats following dermal exposure. The Agency waived the requirement for inhalation data based on high inhalation margins of exposure using an oral endpoint, lack of observed irritation effects, and low vapor pressure. There was no evidence of increased

. Human Health Risk Assessment to Support Proposed New Uses on Caneberry Subgroup 13-07A and Hops” on page numbers 32-37 in docket ID number EPA-HQ-OPP-2019-0070. B. Toxicological Points of Departure/Levels of Concern Once a pesticide's toxicological profile is determined, EPA identifies toxicological points of departure (POD) and levels of concern to use in evaluating the risk posed by human exposure to the pesticide. For hazards

Hand Delivery/Courier: 400 7th Street SW, Suite 3E-218, Washington, DC 20219. Fax: (571) 465-4326. Instructions: You must include “OCC” as the agency name and “Docket ID OCC-2019-0027” in your comment. In general, the OCC will enter all comments received into the docket and publish the comments on the Regulations.gov website

the Unified Agenda is voluntary.[1] The complete Unified Agenda is available to the public at the following website: http://www.reginfo.gov. Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, Public Law 111-203, 124 Stat. 1376 (Dodd-Frank Act), the Bureau has rulemaking, supervisory, enforcement, consumer education, and other authorities relating to